跳至主要内容
临床试验/NCT02498041
NCT02498041已完成不适用

Study to Compare the Efficacy and Patient Tolerance of Ultrathin Nasal Endoscopy to Detect Barrett's Esophagus Compared With Conventional Endoscopy to Inform a Future Multicentre Screening Trial

University of Cambridge0 个研究点目标入组 115 人开始时间: 2009年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
115
主要终点
Endoscopic Diagnostic Accuracy for Barrett's esophagus

研究概览

简要总结

This study evaluates the diagnostic accuracy, safety and acceptability of transnasal endoscopy (TNE) for a diagnosis of Barrett's esophagus (BE). This is a cross-over randomised trial, whereby patients receive two endoscopic procedures 2-4 weeks apart and will be randomised to receive either TNE or standard endoscopy followed by the other procedure.

详细描述

Background: The incidence of esophageal adenocarcinoma (EAC) has drammatically increased in the Western World in the last 30 years. Furthermore it often presents in the late stages and the prognosis remains poor with an overall 5-year survival of 10-15%. Early detection is possible since most cases of EAC develop from a precursor condition, Barrett's esophagus (BE), via a metaplasia-dysplasia-adenocarcinoma sequence. BE can be diagnosed with an upper GI endoscopy.

Un-sedated trans-nasal endoscopy (TNE) may be safer and less expensive than standard endoscopy (SE) for detecting BE. Emerging technologies require robust evaluation before routine use.

Objective: To evaluate the sensitivity, specificity, and acceptability of TNE in diagnosing BE compared with those of SE.

Design:Prospective, randomized, crossover study

Setting:Single, tertiary-care referral center.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age: > 18 years and <75 years
  • Patients who have given informed consent and who are capable of filling in the questionnaire.
  • Patients requiring endoscopy for dyspepsia or follow-up evaluation and patients with a prior diagnosis of BE (defined as minimum Barrett's length of 2cm - according to M level of Prague C & M classification) with specialized intestinal metaplasia on histological confirmation.

排除标准

  • Previous upper GI tract or upper respiratory tract surgery or known upper GI tract abnormality (e.g. pharyngeal pouch).
  • Coagulopathy or on anticoagulants
  • Active or severe cardiopulmonary disease or liver disease
  • Active GI bleeding
  • Patients with alarm symptoms referred to the fast track service and any patient with dysphagia
  • Patients requiring possible endoscopic therapy
  • Patients with high-grade dysplasia or intramucosal carcinoma in BE requiring extensive evaluation and biopsy

结局指标

主要结局

Endoscopic Diagnostic Accuracy for Barrett's esophagus

时间窗: 2 weeks

Sensitivity and specificity for detecting BE using ultrathin endoscopy when compared to gold standard conventional endoscopy will be calculated along with 95% Pearson-Clopper confidence intervals.

次要结局

  • Optical accuracy(2 weeks)
  • Histological diagnosis of Barrett's esophagus(2 weeks)
  • Patient acceptability(12 weeks)
  • Adverse events(1 week)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Massimiliano di Pietro, MD

Senior Clinician Scientist and Consultant Gastroenterologist

University of Cambridge

相似试验

The Efficacy and Patient Tolerance of Ultrathin... | 临床试验